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Abstract
The adult congenital heart diseases (ACHD) population is exceeding the pediatric congenital heart diseases (CHD)
population and is progressively expanding each year, representing more than 90% of patients with CHD. Of these,
about 75% have undergone surgical and/or percutaneous intervention for palliation or correction. Autopsy can be a very
challenging procedure in ACHD patients. The approach and protocol to be used may vary depending on whether the
pathologists are facing native disease without surgical or percutaneous interventions, but with various degrees of cardiac
remodeling, or previously palliated or corrected CHD. Moreover, interventions for the same condition have evolved over
the last decades, as has perioperative myocardial preservations and postoperative care, with different long-term sequelae
depending on the era in which patients were operated on. Careful clinicopathological correlation is, thus, required to
assist the pathologist in performing the autopsy and reaching a diagnosis regarding the cause of death. Due to the
heterogeneity of the structural abnormalities, and the wide variety of surgical and interventional procedures, there are
no standard methods for dissecting the heart at autopsy. In this paper, we describe the most common types of CHDs that
a pathologist could encounter at autopsy, including the various types of surgical and percutaneous procedures and major
pathological manifestations. We also propose a practical systematic approach to the autopsy of ACHD patients.
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Introduction
Over the last 40 years, major advances have been made in
the clinical diagnosis and treatment of congenital heart
diseases (CHD) [1]. These developments have resulted in
an increasing population of patients who survive into
adulthood – the adults with congenital heart disease
(ACHD). ACHD includes a large variety of congenital dis-
orders [2]. Nowadays, the ACHD population is exceeding
the pediatric CHD population and is expanding by an esti-
mated 5% per year. More than 90% of patients with CHD
are adults, and of these, about 75% have undergone palli-
ative intervention or surgical correction [3–7].
Approximately 50% of ACHD patients face complica-
tions during their lifetime, depending on the type of defect
and previous interventions, most commonly arrhythmias,
ventricular dysfunction and heart failure, endocarditis,
need for reoperation (e.g., due to valve or conduit dysfunc-
tion), pulmonary hypertension, and premature or sudden
cardiac death (SCD) [8]. Early diagnosis and treatment
has altered the natural history of CHD and has led to new
and, at times, complex types and patterns of cardiovascular
and lung pathology that increasingly require the attention
of expert pathologists.
Autopsy can be a very challenging procedure in ACHD
patients. The approach and protocol may vary depending on
whether we are faced with cases of native CHD who have
reached adulthood without surgical or percutaneous interven-
tions (but with various degrees of cardiac remodeling) or cases
of previously palliated or surgically/percutaneously corrected
conditions.
Careful clinicopathological correlation is, thus, required
to assist the pathologist in performing the autopsy and
reaching a diagnosis regarding the cause of death. It is
essential that the clinical history, including detailed surgi-
cal reports, is available to the pathologists at the time of the
autopsy.
Clinicians and/or family members who request an autopsy
may wish to obtain information on one or more of the follow-
ing questions:
– Was the clinical diagnosis correct?
– Were there any associated abnormalities/comorbidities
not diagnosed prior to an intervention that could have
impacted on its outcome?
– Was a surgical or interventional procedure (correction or
palliation) performed correctly?
– Was the timing of intervention appropriate?
– Were there any unrecognized complications contributing
to the death of the patient?
For this purpose, a pathologist who performs such an au-
topsy must have good knowledge of the following:
– Morphology of CHDs: Sequential segmental analysis and
knowledge of flow patterns through the morphologically
abnormal heart
– Past and contemporary surgical procedures: For exam-
ple, palliative shunts, vascular grafts, and patches; knowl-
edge of flow patterns in the operated heart; potential
complications
– Percutaneous interventional procedures: For example,
stents, occluder devices, percutaneous valve prostheses
– Postoperative pathology: Residual lesions short- and
long-term complications (e.g., valve degeneration, throm-
bosis, embolic events, endocarditis)
– Patterns of heart remodeling: Hypertrophy, dilatation
and fibrosis, associated with arrhythmia, and heart
failure
– Related pathology in other organs: Pulmonary edema,
pulmonary vascular disease, protein loosing enteropathy,
liver cirrhosis, kidney injury, cerebral abscess
– Syndromic CHD and associated extracardiac
malformations
Due to the heterogeneity of the structural abnormalities
mentioned above, and the wide variety of surgical and inter-
ventional procedures, there are no standard methods for dis-
secting the heart at autopsy. In this paper, we describe the most
common types of CHDs that a pathologist could encounter at
autopsy, including the various types of surgical or interven-
tional procedures and major pathological manifestations. We
also propose a practical systematic approach to the autopsy of
ACHD patients.
The most common congenital heart defects
encountered in adults
Atrial septal defects (ASDs)
Description: ASD is a direct communication between the atria
allowing shunting of blood.
There are four types of ASD, depending on the location of
the defect (Fig. 1a):
& Type 1: Ostium secundum type ASD. This is the most
common type of ASD. The defect is located within the
fossa ovalis (FO), which is about 1–2 cm in diameter,
and often remains undiagnosed until later in life.
& Type 2: Ostium primum defects. These are located inferi-
orly close to the atrioventricular valve and are separated
from the FO by its inferior muscular rim. This type of
ASD is typically part of the spectrum of atrioventricular
septal defects and is associated with abnormal atrioven-
tricular valves (see also atrioventricular septal defect
section)
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& Type 3: Sinus venosus ASD. This can be a superior or an
inferior sinus venosus type of ASD, being related to the
orifice of either the superior or the inferior vena cava
(SCVor IVC), respectively. The superior variant is com-
monly associated with partially anomalous pulmonary ve-
nous connection [9]. The inferior defect is positioned close
to the orifice of the ICV and can be associated with an
anomalous right inferior pulmonary vein.
& Type 4: Coronary sinus defect. It is very rare and located
closely to the ostium of the coronary sinus (CS). It is due
to deficiency of the walls of the coronary sinus allowing
shunting with the left atrium (LA) [10].
Most ASD cases are sporadic and very few run in families
in an autosomal dominant pattern [11]. Ostium primum de-
fects are common in individuals with Down syndrome or
Ellis-Van Creveld syndrome. One third of ASD occur in as-
sociation with other cardiac malformations [12].
Symptoms related to ASDs depend on the size of the defect
and associated lesions/comorbidity. Many patients remain
asymptomatic for many years and may remain undiagnosed
throughout their lives, while others present in childhood.
ManyASDs are nowadays diagnosed after the age of 40 years.
Symptoms include arrhythmia, paradoxical embolism, right
ventricular failure, and, more rarely, cerebral abscess and pul-
monary hypertension.
ASD causing significant left-to-right shunting or other
complications should be repaired, unless pulmonary vascular
disease has developed. Most cases of secundum ASD are
nowadays closed percutaneously, using an occluder device.
Failure to align the device can result in device embolization
and is likely to occur in very large defects (>/ = 35 mm), with
absent or deficient posterior or inferior rim. Moreover, percuta-
neous closure may be challenging in cases with a multi- fenes-
trated and/or aneurysmal atrial septum or proximity of the FO to
the venous orifices [13, 14] (Table S2 supplement). When a
transcatheter approach is not feasible or a primum or sinus
venosus ASD is present, open-heart surgery is required to close
the defect with a graft or prosthetic patch [15, 16] (Table 1).
Autopsy recommendations
Autopsy should identify the location, type, and size of an
unrepaired ASD, as well as associated lesions. Moreover, dilata-
tion of the RA and LA, tricuspid valve annular dilatation, and
dilatation (and at times hypertrophy) of the right ventricle (RV)
are typically encountered. Pulmonary artery dilatation is common,
while atheromatous changes in the pulmonary arteries and signif-
icant RV hypertrophy suggest pulmonary hypertension.
Histology of the lungs is essential to detect vascular changes.
In repaired ASDs, the position and size of surgical patches
and closure devices, as well as residual communications, should
be described. Displacement or embolization of a device and de-
hiscence of a surgical patch should be excluded. After timely
successful repair, the heart is expected to remodel toward normal.
Both patches and devices become endothelialized 6–12 months
after intervention and may be difficult to identify. Late compli-
cations include thrombosis of the device and embolic phenomena
(stroke or coronary artery and systemic embolization), complete
heart block, and infective endocarditis. Moreover, rare cases of
Fig. 1 Drawings of the most common types of atrial (a), atrioventricular (b) and ventricular septal defects (c), and their locations inside the cavities
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device erosion toward the aorta have been described [17]
(Table 1, Table S2 supplement).
Atrioventricular septal defects (AVSD)
Description: AVSDs (synonyms: atrioventricular canal defects
or endocardial cushion defects) are characterized by a common
atrioventricular junction and a common atrioventricular valve
resulting in communication between the atria and ventricles
and all four cardiac chambers, depending on the anatomical
severity (Fig. 1b). Down’s syndrome is commonly associated
with AVSDs, present in one third to one half of all patients.
There are several types of AVSDs
The ostium primum defect (or incomplete AVSD) (see also ASD
section) has a common atrioventricular junction. The bridging
leaflets of the atrioventricular valve are joined together and are
adherent to the crest of the ventricular septum forming two sep-
arate valve orifices that are often regurgitant. As a result, shunting
across the defect occurs only at atrial level [18]. Surgery abol-
ishes the shunt and associated overload to the RVwhile repairing
or, more rarely, replacing the atrioventricular valves [19].
The complete form of AVSD is characterized by having a
communication allowing both interatrial and interventricular
shunting, a common atrioventricular valve orifice and a five-
leaflet valve, most often dysplastic, but with the bridging leaf-
lets not adherent to the atrial septum or the crest of the ven-
tricular septum. Surgical correction with closure of interatrial
and interventricular components, along with repair and recon-
struction of atrioventricular valves, is done. After repair of an
AVSD, a re-intervention may be needed for left-sided valve
insufficiency or stenosis, often years after repair, with rate of
re-intervention of about 10% [20].
Complete AVSDs can be classified into balanced and un-
balanced according to the relative dimensions of the ventri-
cles. In unbalanced AVSDs, one of ventricles is too small/
hypoplastic and may be deemed unsuitable for a biventricular
repair. These cases require a staged single-ventricle palliation
with a Fontan or Fontan-like procedure [20] (Table 1).
Autopsy recommendations
Unoperated cases are almost never seen in the adult popula-
tion and are usually partial AVSDs (primum ASDs). Adults
with unrepaired complete AVSDs typically present with se-
vere pulmonary vascular diseases (Eisenmenger syndrome).
In repaired cases, patches and sutures are usually re-
endothelialized and calcified for months or years following
surgery. The presence of residual VSD and ASD, left-sided
valve pathology (stenosis or regurgitation, surgery, endocardi-
tis), subaortic or pulmonary stenosis, and myocardial remod-
eling of atria and ventricles with histologic examination of
fibrosis (risk of arrhythmia) all needs to be evaluated at autop-
sy. Finally, pulmonary vascular disease and endocarditis
should be excluded. In palliated cases, the presence of banding
of the pulmonary trunk or a Fontan-type circulation (see later)
should be described (Table 1).
Ventricular septal defects (VSDs)
Description: A group of common congenital heart defects
characterized by holes in the ventricular septum.
There are severa l types of VSD (Fig . 1c) : A
perimembranous has the membranous septum incorporated
into its postero-inferior border.Muscular VSDs are completely
surrounded by muscle and can be located anywhere in the
muscular ventricular septum. Subarterial VSDs (synonyms:
supracristal, doubly committed or juxta arterial defects) are
immediately adjacent to both the aortic and pulmonary valves
and may have perimembranous or muscular border.
Patients with certain genetic abnormalities, e.g., Down syn-
drome, have a high incidence of associated VSDs: VSD is an
integral part of tetralogy of Fallot, and VSDs are present in
most patients with univentricular circulation or transposition
of the great arteries.
VSDs with a maximal size of 2 mm or less are likely to
close prenatally, while others may close within the first
10 years of life [21]. Residual scarring in the septum or scar-
ring with aneurysmal dilatation of the membranous septum
with redundant tricuspid valve tissue may be seen at autopsy
at the site of spontaneously closed defect.
Persistent VSDs are often restrictive but may be larger.
Large or multiple VSDs can lead to pulmonary hypertension
and right ventricular hypertrophy, eventually with the devel-
opment of Eisenmenger syndrome characterized by shunt re-
versal and cyanosis. Patients with a VSD and significant, ir-
reversible pulmonary vascular disease are deemed inoperable.
For this reason, timely surgical closure is recommended for
all large perimembranous VSDs, supracristal VSDs, and
VSDs with aortic valve prolapse [22]. Muscular VSDs may
be closed by percutaneous techniques. A large number of
devices have been used for VSD occlusion, the Amplatzer
VSD occlude device being the most popular (Table 1).
Autopsy recommendations
Surgical patches can be calcified and fibrosed, or largely in-
corporated into the ventricular septum many years after sur-
gery, and can be difficult to identify. Postoperative complica-
tions that should be searched for are the following: dehiscence
of the patch, heart block in perimembranous septal defects
(due to surgical damage of left bundle branch), infective en-
docarditis (operated and non-operated cases), and patch-
related thrombus or embolization. In case of supracristal de-
fects, accompanying aortic regurgitation is common,
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produced by prolapse of the anterior aortic leaflet. Residual
VSDs should be identified and described (e.g., suture dehis-
cence). Muscular VSDs may be more difficult to identify.
Remodeling of the LV and RV should be described, and lung
histology is required to identify and grade pulmonary vascular
disease. The presence of pacemakers for permanent pacing
may indicate manifestations of complete heart block during
life (Table 1, Table S2 supplement).
Truncus arteriosus or common arterial trunk
Description: The common arterial trunk (CAT), also known as
truncus arteriosus, is a rare type of CHD (1–3% of cases) and
therefore mentioned only briefly here.
The anomaly is characterized by a single (common) arterial
trunk overriding a large VSD, supplying the coronary, system-
ic, and pulmonary arterial system. The latter arises from the
common trunk either as separate right and left pulmonary ar-
teries or as a single pulmonary trunk that subsequently bifur-
cates. This common trunk is guarded by a truncal valve, which
is always in continuity with the mitral valve. In most cases,
there is usual atrial arrangement (situs solitus) and concordant
atrioventricular connections. In majority of cases, the truncal
valve has three leaflets and is grossly dysplastic and incompe-
tent, but it may also be stenotic. Approximately 30% of truncus
arteriosus cases are associated with a genetic syndrome, fre-
quently DiGeorge syndrome with 22q11deletion. The most
significant variation in the aortic pathways associated with
CAT is severe coarctation or complete interruption of the aortic
Table 1 Major congenital cardiac defects and autopsy considerations
after surgical procedures
Type of defects Considerations after surgical procedures
ASD Residual defect after patch or device closure
Size of the right and left atria
Size of the right and left ventricular chambers
Pulmonary vascular disease
AVSD Relative size of the ventricles: unbalanced type,
with one dominant and one hypoplastic
ventricle
Left and right atrioventricular valve incompetence
Left and right atrioventricular valve dysplasia
Subaortic or subpulmonary obstruction due to left
atrioventricular valve replacement or
ventricular patch
Residual VSD or ASD
Pulmonary vascular disease
Complete heart block
Sudden death
Endocarditis
VSD Residual defect after patch or device closure
AV node/conduction tissue damage/dysfunction
Remodeling of the right or left ventricle
Aortic or tricuspid valve incompetence
Endocarditis
Truncus arteriosus RV-PA conduit stenosis, incompetence or
infection
Truncal valve regurgitation, stenosis or infection
Prosthetic valve dysfunction or endocarditis
Coronary arteries anomalies leading to
myocardial damage
Residual VSD
Truncal root dilatation
Pulmonary artery stenosis
Pulmonary vascular disease
Tetralogy of Fallot Pulmonary valve regurgitation
Residual VSD
Residual pulmonary/ right ventricular outflow
tract stenosis
Ventricular or atrial tachyarrhythmias
Endocarditis
RV-PA conduit dysfunction
Aortic root dilatation (± aortic valve
regurgitation)
Right and/or left ventricular dysfunction
Congestive heart failure
Congenital aortic
valve disease
Aortic valve stenosis or incompetence
LV hypertrophy, dilatation, and/or dysfunction
Aortic dilatation
Ross procedure: pulmonary valve prosthesis,
coronary artery re-implantation, dilatation of
the neo-aorta
Bentall procedure: coronary artery
re-implantation
Conduction abnormalities
Endocarditis
Aortic coarctation Re-coarctation (most common with end-to-end or
percutaneous repair)
Associated defects: bicuspid aortic valve,
subaortic stenosis, mitral valve disease,
ascending aortic dilatation.
(Pseudo) aneurysms at the site of previous repair
Table 1 (continued)
Type of defects Considerations after surgical procedures
Infective endocarditis or arteritis
Cerebral berry aneurysm rupture
Aortic dissection
Premature coronary artery disease
Left ventricular hypertrophy/remodeling
(D-)TGA After Mustard or Senning procedure: systemic
ventricular morphology, scarring, tricuspid
valve abnormalities, pathway obstruction,
baffle leaks, pulmonary stenosis, pulmonary
vascular disease, subpulmonary LV size and
function
After arterial switch procedure: Coronary artery
abnormalities/distortion, neo-aortic root
dilatation, neo-aortic valve regurgitation, right
ventricular outflow tract obstruction, ventricu-
lar remodeling
Pulmonary valve
disease
Pulmonary/ prosthetic valve stenosis or
incompetence
Right ventricular remodeling
Right ventricular scarring
Aneurysmal dilatation of the pulmonary artery
Endocarditis
Virchows Arch
arch, with the proximal aorta arising directly from the common
trunk and the distal aorta fed through a patent arterial duct.
Without surgical repair, most truncus arteriosus patients die in
early life, most frequently due to severe pulmonary arterial hyper-
tension (PAH) or from heart failure and associated low flow con-
ditions such as myocardial ischemia and necrotizing enterocolitis.
Surgical repair is indicated in the neonatal period, or by 2–
3 months of age due to the rapid progression of pulmonary
vascular disease. Repaired cases achieve an 80% long-term
survival [23]. The aim of surgical repair is to restore a normal
physiologic circulation. The pulmonary arterial trunk (or
branches) is detached from the truncus and attached to the right
ventricle (RV) via a homograft (a valve conduit). The VSD is
closed with a patch. The truncal valve becomes the neo-aortic
valve, and, if necessary, it is repaired or replaced by an aortic
homograft with coronary artery re-implantation (Table 1).
Autopsy recommendations
In surgically repaired CAT adult patients, the pathologist has
to look for a possible residual VSD in relation to the patch,
truncal valve regurgitation or stenosis due to dysplastic leaf-
lets, or prosthetic valve dysfunction, aortic (truncal) root dila-
tation, coronary artery abnormalities, stenosis or incompe-
tence of the valved conduit right ventricular outflow or pul-
monary artery stenosis, and, importantly, endocarditis.
Histological examination of the myocardium and lungs is re-
quired to evaluate early and late scaring and the presence of
pulmonary vascular disease (Table 1, Table S2 supplement).
Pulmonary stenosis
Description: Pulmonary stenosis is a common type of CHD
and is frequently isolated but can also be associated with sim-
ple or complex congenital cardiac defects.
The stenosis can be valvular, localized at the site of pulmo-
nary valve or its annulus, or, more rarely, in the subvalvular
(muscular) infundibulum of the RV, or supravalvular in the pul-
monary trunk or its branches. In pulmonary valvular stenosis, the
valve is typically a dome-shaped diaphragm with a central per-
foration without recognizable leaflets. Isolated infundibular
stenosis is frequently associated with a VSD. Restrictive VSDs
can be associated with hypertrophic muscular bundles within the
RV causingmid-ventricular obstruction (double-chamberedRV).
Supravalvular stenosis is a circumferential fibrous ring that
obstructs the pulmonary trunk, the main pulmonary branches,
or even the distal branches with multiple stenoses typical of
Williams syndrome.
The stenosis can be relieved by percutaneous dilatation with
balloon (angioplasty) or by surgical maneuvers such as pulmo-
nary commissurotomy, complete or partial removal of the mal-
formed leaflets with or without enlargement of the annuluswith a
transannular patch. The presence of infundibular obstruction can
be addressed through the pulmonary valve annulus if not too
hypoplastic, or through the tricuspid valve ventriculotomy,which
is rarely required nowadays for the resection of the hypertrophic
muscle bands, as it is associated with long-term complication
(RV dysfunction, ventricular tachycardia). In supravalvular ste-
nosis, it is necessary to enlarge the pulmonary trunk with autol-
ogous or heterologous pericardium or with Gore-Tex (Table 1).
Autopsy recommendations
In adult patients with unoperated pulmonary stenosis, the pa-
thologist has to evaluate the level at which obstruction occurs.
Secondary changes due to the pulmonary valve anomaly are
RV hypertrophy, tricuspid valve insufficiency, and RA dilata-
tion. Poststenotic dilatation affects the pulmonary trunk or its
left branch. Surgically treated cases should be examined for
pulmonary valve incompetence, RV dilatation, and ventricular
scarring. After percutaneous or surgical valve implantation,
evaluate the position of the valve, residual stenosis, and valve
complications such as paravalvular leak, endocarditis, and
calcification of the leaflets (Table 1, Table S2 supplement).
Tetralogy of Fallot
Description: The defining anatomical abnormalities of the te-
tralogy, as described by Étienne Fallot in 1888, are VSD with
overriding aorta, pulmonary stenosis, and right ventricular
hypertrophy (RVH).
TOF is themost common cyanotic CHD accounting for up to
9% of CHD [24]. It can be associated with trisomy 21, trisomy
18, trisomy 13, and DiGeorge syndrome, but in most patients,
no genetic association can be found. Congenital abnormalities
associated with ToF include bicuspid pulmonary valve, left pul-
monary artery stenosis, coronary artery anomalies, right-sided
aortic arch, anomalous pulmonary venous return, and skeletal
abnormalities of the vertebrae and ribs [25–27].
The severity of right ventricular outflow tract obstruction is
variable, but when severe, there is right-to-left shunting
through the VSD and systemic cyanosis. Most adult cases
encountered nowadays in developed countries will have had
reparative surgery early in life, with takedown of any previous
palliative shunt (Table 1).
Definitive repair consists of patch closure of the VSD, with
the overriding aorta supplied only by the LV and relief of
pulmonary and subpulmonary stenosis by infundibular re-
modeling and/or a transannular patch. Surgical closure of the
VSD may be done through a right ventriculotomy (more tra-
ditional approach) or with a transatrial approach through the
tricuspid valve (more recent technique) (Fig. 2). Recently, a
surgical technique with pulmonary valve reconstruction has
been proposed by several authors to avoid or minimize the
long-term pulmonary valve regurgitation that is inevitable
with the traditional techniques [28–30] (Table 1).
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Nowadays, the life expectancy of patients with repaired
ToF is felt to be similar to the general population [31], even
though there persists a small risk of sudden cardiac death at all
ages [32], and pulmonary regurgitation is common which fre-
quently requires further intervention.
Early complications after repair include residual VSD, right
ventricular outflow tract obstruction or pulmonary stenosis,
and ventricular tachyarrhythmias (Table 1). Later complica-
tions include pulmonary regurgitation, progressive dilatation
of the aorta with secondary aortic valve incompetence, pro-
gressive right ventricular dilatation, or aneurysm, following
extensive ventriculotomy, infundibular remodeling, or
transannular patching, and tricuspid valve incompetence.
Patients with pulmonary atresia, at the extreme end of the
spectrum of ToF, require an RV to PA conduits at repair, which
typically becomes stenotic or regurgitant over time; a synthet-
ic conduits may develop neointimal hyperplasia, while homo-
graft conduits and valves tend to calcify.
Previous palliative shunts, right ventricular hypertrophy
with fibrosis (Fig. 3), a prolonged QRS duration, ventricular
dysfunction, and atrial arrhythmias have been shown to be
predictors of death and sustained VT [33]. Patients felt to be
at significant risk of sudden death may be offered an ICD as a
primary prevention [34].
During adult life, reoperation for pulmonary valve re-
gurgitation is often required in the presence of severe RV
dilatation, RV dysfunction, and associated symptoms or
progressive tricuspid regurgitation, with very low surgical
risk [35]. Several types of bioprosthetic valves, homo-
grafts, and, more recently, percutaneous pulmonary valves
are used in these patients, depending on availability and
anatomical features [36] (Fig. 4) (Table 1, Tables S2 and
S3 supplement).
Autopsy recommendations
On external examination, there are typically the scars of pre-
vious operations, sternotomy or thoracotomy. In patients dy-
ing of heart failure, there may be systemic signs of right or
biventricular failure, while internally, there may be pleural
effusions, pulmonary edema, ascites, and hepatic congestion.
Fibrosis and calcification of operation sites, patches, and con-
duits may be present, with possible stenosis or infection of
conduits. Pulmonary and tricuspid valve competence should
be assessed, and ventricular size should be measured. Right
ventricular hypertrophy and fibrosis may be the substrate for
fatal arrhythmia. Endocarditis may be an early or late compli-
cation of the original surgery (Fig. 2) or later valve replace-
ments and is often associated with septic emboli in the lung.
Percutaneous pulmonary valve implants appear to be prone to
infective endocarditis, which is often obstructive. Older pa-
tients may have developed superimposed atheroma of native
coronary vessels (Table 1, Tables S2 and S3 supplement).
Fig. 2 Diagram of ToF after surgical repair, with a patch inserted to enlarge
the pulmonary valve and the RV outflow tract (*) and closure of the
interventricular defect with a patch (ç) (a). Operated TOF at adult age; the
patient died of heart failure (b, c, d). Anterior view of the heart with
transannular patch (*) and dilatation of the right ventricle with enlargement
of the right heart silhouette (b); internal view of the RVoutlet showing the site
of the ventricular septal defect closed by an endothelialized patch (ç) and
dilatation of the RV (c); close view of the calcified RVoutflow patch (*) (d)
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Left ventricular outflow tract obstruction (LVOTO)
Description: LVOTO in adults includes a series of stenotic le-
sions which can be single or at multiple sites along the tract.
Obstruction can be subvalvular, valvular, and/or supravalvular.
Valvular AS is the most frequent form, accounting for 75% of
LVOTO cases, while subvalvular and supravalvular account for
20–25% and 5–7%, respectively. AS can occur in isolation or in
association with other forms of CHD such as VSD, mitral valve
disease, or aortic coarctation (Shone complex).
Fig. 3 Histology of RV wall of an adult patient with operated ToF. Transmural section showing hypertrophic myocardium and fibrosis of interstitial
reactive and replacement type. Elastic van Gieson stain
Fig. 4 Hybrid procedures in a case of ToF with previous surgery and stenting of the pulmonary valve with a percutaneous intervention, using aMelody
valve
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Valvular stenosis is the most common cause of bicuspid
aortic valve (BAV), with an estimated prevalence of 1–2%
in the general population [37]. BAV represents the most com-
mon cause of aortic valve replacement or implantation in adult
population < 70 years, due to leaflet calcification (Fig. 5).
There is complete absence of one of the commissures or pres-
ence of a, often heavily calcified, ridge (“raphe”) between two
cusps, resulting in a functionally bi-leaflet valve. It is recom-
mended to describe the orientation of commissural anomaly of
these valves: absent commissure (or raphe) between the left
and the non-coronary (LC-NC) or between the right and the
non-coronary leaflets (RC-NC, more frequently associated
with aortic coarctation) or between the left and right cusps
(LC-RC, more frequently associated with dysfunction and
aortic root dilatation). Dilatation of the ascending aorta bears
a related risk, albeit still rare, of aortic dissection and rupture
with hemopericardium due to medial degeneration. One half
of aortic dissections in the youth are associated with BAV.
BAV may be hereditary, and cardiological screening of the
family, including echo, is advisable. Much rarer valve abnor-
malities are the tricuspid aortic valve due to dysplastic leaflets,
with thickening or partial commissural fusions or annular hy-
poplasia; the quadricuspid valve (four normal-looking leaflets
or with a double “raphe”); and the unicuspid aortic valve (sin-
gle cusp with an eccentric “keyhole” or a dome-like appear-
ance) and can be associated with a hypoplastic aortic annulus
and ascending aorta. Subvalvular stenosis includes a wide
range of anomalies from a discrete fibroelastic membrane/
ring to a tunnel-like fibromuscular band. It can be complicated
by valvular stenosis or with other abnormalities of the
subaortic region, such as anomalous accessory mitral leaflet
or accessory muscular band. Supravalvular stenosis is charac-
terized either by a discrete focal stenosis at the sinotubular
junction due to thickening of the aortic wall (seen in
Williams Syndrome) [38], or an isolated fibrous membrane,
or diffuse tubular hypoplasia of the ascending aorta and
brachiocephalic vessels.
Patients may present very early in life or remain asymp-
tomatic for many years. Progression of AS depends on the
anatomical features of the valve and the degree of
superimposed degenerative calcification or atherosclerosis.
Symptomatic lesions in adults are surgically treated, with
valves sent to the pathologist as a surgical specimen, but
sometimes be found at autopsy, the cause of a severely
hypertrophied left ventricle (or dilatation when the valve is
severely regurgitant) (Table 1, Tables S2 and S3 supplement).
Autopsy recommendation
At autopsy, the pathologist should identify the type and loca-
tion of LVOT stenosis or obstruction, including accessory fi-
brous tissue, aortic valve anatomy, and extent of calcifications
and signs of endocarditis. The ascending aortic diameter/
circumference and aortic wall thickness should be measured
to evaluate stenosis, ectasia/aneurism, and atherosclerosis.
In all cases, native valve anatomy should be evaluated. In
patients with aortic dissection spontaneous or procedure relat-
ed, the presence of a BAV should be recorded (see above). In
cases of transcatheter aortic valve replacement (TAVR), the
valve bearing stent should be removed carefully.
Fig. 5 Bicuspid aortic valve in a 50-year-old man, with dystrophic calcification causing aortic valve stenosis
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Histological examination of the aortic wall is recommend-
ed, with hematoxylin-eosin and elastic van Gieson stains, to
establish type and severity of aortopathy (medial degenera-
tion). The aortic arch should be inspected, to rule out isthmic
coarctation.
In all cases, left ventricular size and parietal wall thickness
should be assessed (hypertrophy, dilatation, scars) also in re-
lation to the RV dimensions. The diameter of the aorta at the
aortic annulus (at the level of ventriculo-arterial junction),
sinotubular junction, and tubular portion of the ascending aor-
ta should be recorded.
The results of percutaneous valvuloplasty, surgical
valvulotomy, and percutaneous or surgical replacement
should be evaluated:
1. Acute or short-term procedure-related complications:
Hemorrhages (paravalvar), hematomas (check topograph-
ic relation with conductive tissues); aortic root lacerations,
dissection, thrombosis, and endocarditis; correct position
of implant, patency, and (paravalvar) leakage; and throm-
boembolic complications.
2. Long-term complications (> 6 weeks): Correct position of
implant, patency/stenosis, paravalvar leakage (probe), and
ingrowth/encapsulation; endocarditis and thromboembol-
ic complications; and excessive fibrosis and calcifica-
tions. Always check entire LVOT and mitral valve (spe-
cifically anterior leaflet).
A cerebral autopsy is recommended to evaluate potential
thromboembolic complications. Eventual associated
syndromic pathology should be recorded.
Cardiogenetic consultation should be advised or recom-
mended, both in the proband and relatives, when hereditary
disease is suspected (Table 1, Tables S2 and S3 supplement).
Coarctation of the aorta (CoA)
Description: CoA is a focal or segmental congenital narrowing
of the aorta [22].
It usually occurs near the ductus/ligamentum arteriosum, in
a para-, pre- or postductal location, causing a discrete aortic
lumen narrowing or a hypoplastic segment of the aorta [22,
39, 40] (Fig. 6a). Often, discrete CoA and tubular hypoplasia
can co-exist. CoA can occur as an isolated form or be associ-
ated with other vascular malformations or syndromes [41].
About 15–20% of affected individuals are asymptomatic until
adulthood (Fig. 6b). Without repair, adult CoA has a high
mortality rate (75% by the fifth decade of life). Therapeutic
approach includes balloon dilatation, stent implantation, or
surgery (end-to-end anastomosis, prosthetic patch or subcla-
vian flap aortoplasty, or interposition of graft). All the
methods may fail leading to re-coarctation and/or have com-
plications [42–45] (Table 1, Tables S2 and S3 supplement).
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Fig. 6 Diagram of the different types of CoA (a). A case of an adult
patient with asymptomatic aortic coarctation (arrows without tail), who
died because of iatrogenic laceration and dissection (white arrows) of the
aorta during percutaneous aortic valve implantation. (TA, thoracic aorta).
The patient also had bicuspid aortic valve (b)
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Autopsy recommendations
Evaluate the size of the aortic arch and isthmus, the thickness of
the aortic wall at the site of narrowing. Look for signs of hyper-
tension in the upper part of the body (atherosclerosis of the large-
andmedium-size arteries), LV hypertrophy, congestive heart fail-
ure, coronary artery disease, stroke, endarteritis, cerebral berry
aneurysms, and aortic dissection. Histopathological features ob-
served in the unoperated CoA include disorganized or
fragmented elastic fibers, extracellular mucoid medial accumula-
tion (MEMA) [45], and in adults myofibroblastic proliferation
and atherosclerosis.
In case of death early after repair, lacerations of the aortic wall,
adventitial hematomas, and thrombosis/thromboembolism
should be sought for. Late after repair, false aneurysm and infec-
tious endarteritis (with associated embolic risk), at the site of
repair may be encountered (Table 1, Tables S2 and S3
supplement).
Complete transposition of the great arteries (D-TGA)
Description: Anatomically, the combination of concordant AV
connections (the atria are connected to the correct/respective
ventricles) and discordant VA connections (the ventricles are
connected to the incorrect great arteries) results in systemic
venous return being sent to the systemic circulation and pul-
monary venous return sent back to the lungs (Fig. 7A).
For survival, a large ventricular or atrial communication is,
thus, necessary to allow mixing of blood [46]. Over 60% of
cases occur in isolation and require early atrial septostomy; the
remaining are associated with other congenital defects, mainly
VSD or obstruction of the (subpulmonic) left ventricular
outflow tract (LVOT) or both (30%). Most commonly, the
aorta is located in right anterior position relative to the pulmo-
nary trunk.
In the absence of a large interatrial (ASD) or interventricu-
lar communication (VSD), the newborn with complete trans-
position usually succumbs rapidly upon closure of the oval
fossa and the arterial duct due to severe desaturation of the
arterial blood. This requires immediate surgical palliation by
means of balloon atrial septostomy (Rashkind procedure [47,
48]) to improve hypoxemia. Permanent surgical correction
can be achieved at a second stage by means of either atrial
switch procedure (so-called physiological correction, Mustard
[49] or Senning procedure [50], currently abandoned)
(Fig. 7B) or, nowadays, arterial switch procedure (anatomical
correction, Jatene procedure, (Fig. 7C) with excellent early
and late-term survival and outcomes) [51] (Fig. 8) (Tables 1
and 2).
Autopsy recommendations
At autopsy, adult patients are nearly always repaired, and pa-
thology relates to the type of surgical procedure undertaken.
Arterial switch procedure is presently the preferred choice and
performed ideally within 2 weeks from birth. Aorta and pul-
monary trunk are transected close to their valves for re-
implantation; hence, the pulmonary valve becomes the “neo-
aortic” valve, and the aortic valve becomes the neo-pulmonary
valve. This procedure also requires (microsurgical) retrieval of
the proximal coronary arteries, with re-implantation of their
ostia over the neo-aortic valve. In addition, the procedure in-
cludes the reconstruction of the pulmonary trunk with pericar-
dial patch (Table 2). Long-term complications include aortic
Fig. 7 Transposition of the great arteries (a–c): Drawing of the native
defect, with the aorta originating from the RV and the pulmonary artery
from the left ventricle (a). Drawing of the atrial switch (Mustard or
Senning procedure), redirecting the systemic venous blood flow into the
left ventricle and the pulmonary trunk, and the oxygenated blood from the
lungs into the right ventricle and the aorta (b). Drawing of the arterial
switch procedure with repositioning the great vessels above the
appropriate ventricles and re-implantation of the coronary arteries (c)
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root dilatation with possible aortic valvar insufficiency, left
ventricular failure, and myocardial ischemia. RVOT obstruc-
tion, and stenosis of branching pulmonary arteries, can occur
when the pulmonary trunk had to be repositioned anterior to
the aorta (LeCompte procedure). Inspection of coronary ostia
and proximal course of the coronary arteries (scarring) is im-
portant to rule out kinking and/or acquired atresia.
The atrial switch procedure (Mustard or Senning) (Fig. 7B,
Table 2) is now largely abandoned in favor of arterial switch
(Fig. 7C) and is commonly encountered in older adults with
D-TGA. This procedure includes resection of the atrial
septum, which is replaced by a “baffle” that channels the
superior and inferior caval blood to the pulmonary
circulation via the subpulmonary left ventricle, whereas the
pulmonary venous blood is channeled from behind the
baffle toward the tricuspid valve and systemic RV and
tricuspid valve.
On autopsy, severe hypertrophy and dilatation of the RV are
observed, with tricuspid insufficiency and deviation of the septum
toward the LV unless LVOT obstruction is present. Surgical
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Fig. 8 Transposition of the great arteries after Mustard correction at adult
age (a–d). Outflow tract of left ventricle is connected to the pulmonary
artery (a). Outflow of the right ventricle is connected to the aorta, with
“anomalous” origin of the coronary arteries (b). Anterior (atrial) baffle
directing the caval blood toward left ventricle (c). Pulmonary venous
baffle (with prosthetic material visible) directing blood toward the tricus-
pid valve and right ventricle (d)
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damage to conduction system, extensive fibrosis due to ventricular
remodeling of the RV, and atrial scarring due to surgery are sub-
strates for the frequently occurring atrial and ventricular arrhyth-
mias and instances of sudden death. In addition, the presence of
baffle stenosis or leaksmust be evaluated, occurring in a quarter of
patients. Finally, the presence of endocarditis should be assessed.
Cases of unrepaired TGA, typically with a large VSD, are
rare in adult life and are typically associated with Eisenmenger
syndrome, in the absence of pulmonary stenosis, i.e., severe
pulmonary vascular disease (Tables 1 and 2, Tables S1, S2 and
S3 supplement).
Congenitally corrected transposition of great arteries
(CCTGA)
Description: Discordant atrioventricular and ventriculo-
arterial connections (double discordance) result in a “physio-
logically correct” circulation through the heart in the absence
of associated defects.
However, long-term outcome depends on adaptation of the
RV and tricuspid valve to support the systemic circulation,
similar to what was described for TGA patients after atrial
switch repair [52]. Commonly associated defects include a
VSD, pulmonary stenosis, and “Ebstein-like” malformation
or other tricuspid valve pathology (15–80%) causing regurgi-
tation [53]. In the absence of associated defects and a well-
adapted systemic RV, ccTGA can remain asymptomatic for
decades and may be diagnosed very late in life or at autopsy.
However, the intrinsic abnormality of the AV conduction
system, with the AV node aberrantly located anteriorly and
the His bundle on the pulmonary outflow, puts ccTGA pa-
tients at risk of wear and tear injury, which explains onset of
AV block and cardiac arrest. Reportedly, one half of this pa-
tient population requires a pacemaker [54] (Table 1).
Autopsy recommendations
Autopsy should start with establishing the viscero-atrial situs,
atrioventricular and ventriculo-arterial connections. The position
of the aorta in relation to the pulmonary trunk should be recorded,
as well as eventual associated lesions. The wall of the morpho-
logic (subpulmonary) LV is typically thin, while the morphologic
(systemic) RV is dilated and severely hypertrophied. Tricuspid
regurgitation with either abnormal valve leaflets (Ebstein-like)
or due to annular dilatation is a frequent complication in the adult,
with right ventricular (systemic) failure occurring in patients >
50 years or earlier and an increased risk of endocarditis.
When examination of AV conduction system is required, it
should be noted that, in hearts with situs solitus, the coronary
sinus and triangle of Koch are not a point of reference for
sampling tissue blocks (Table 1).
Ebstein anomaly of the tricuspid valve
Ebstein anomaly (EA) is rare (< 1% of all CHD cases). It
usually occurs sporadically, but familial cases have been
reported.
Table 2 Most important types of
systemic to pulmonary artery
shunts and definitive repairs
Blalock-Taussig shunt Subclavian artery directly anastomosed to pulmonary artery (right or left)
Modified Blalock-Taussig shunt Conduit of synthetic material between subclavian artery and pulmonary artery
Mee procedure Ascending aorta to main pulmonary artery
Waterston shunt Ascending aorta to right pulmonary artery
Potts shunt Descending aorta to left pulmonary artery
Standard ToF repair Closure of the VSD and relief of the pulmonary/RVOT stenosis
Variants of ToF repair Right atrial approach versus right ventriculotomy preserving PV versus
transannular patch
Rastelli procedure A Gore-Tex patch tunneling the lef ventricle to the aorta, closing the VSD. The
pulmonary valve is surgically closed and an artificial conduit and valve from the
right ventricle to the pulmonary bifurcation
Atrial switch procedures
(Mustard or Senning)
A two-way baffle in the atria connects the SVC and IVC to the left ventricle and the
PV to the right ventricle. In a Senning procedure, the baffle is made with peri-
cardium of the pt.; in the Mustard procedure, a synthetic material is used
Arterial switch (Jatene
operation)
The left and right coronary arteries are removed from the Ao and re-anastomosed to
the adjacent pulmonary artery, which was to become the neo-aorta, and by
transecting and transposing the aorta and main pulmonary artery
Da Silva Extensive leaflet mobilization, longitudinal plication of the atrialized ventricle, and
cone-shaped reconstruction of the tricuspid valve, allowing for leaflet-to-leaflet
co-aptation.
Glenn The SVC is connected to the right pulmonary artery
Fontan Direct atriopulmonary connection (right atrial appendage to pulmonary trunk which
has been detached from the pulmonary valve)
Fontan modified The IVC is disconnected from the heart and inserted into the pulmonary artery. A
conduit can be interposed between the IVC and the PA and can be fenestered.
The right ventricle become the systemic ventricle connected the Ao. The SVC is
connected to the PA
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Description: The anatomical hallmark is displacement of
the tricuspid hinge line (annulus) toward the RVapex affecting
the septal and posterior leaflets.
This apical displacement of the valve results in the
pretricuspid part of the RV becoming “atrialized” and thin-
walled [55]. Ebstein anomaly is often associated with an atrial
septal defect or patent foramen ovale, which may allow left to
right shunting and cause systemic desaturation. Wolff-
Parkinson-White syndrome (WPW) is present in up to 30%
of patients. RV outflow tract obstruction is more often ob-
served in young patients.
Symptoms depend on the severity of tricuspid regurgitation
and size of the “functional”RV. This size is variable but can be
limited to the outflow tract only, which then becomes dilated
and hyperdynamic. Accordingly, the clinical presentation may
vary from asymptomatic in very mild cases to deep cyanosis
and heart failure (mostly in neonatal cases). Arrhythmias are
common in adult life, and there is an increased risk of sudden
death [56]. Wolff-Parkinson-White syndrome (WPW) is asso-
ciated in up to 30% of patients.
Surgical repair with implication of the atrialized portion of
the RVand closure of associated septal defects is the preferred
option. Currently, the most commonly used technique is the
“cone” reconstruction technique described by Da Silva, [57]
(Table 2), which creates a cone-looking tricuspid valve from
the available leaflet materials [58]. Rarely, when reconstruc-
tion is impossible, the valve is replaced with a bioprosthetic
valve. Some patients may also undergo bidirectional Glenn
anastomosis (anastomosis of the superior vena cava to the
right pulmonary artery) to reduce RV preload and the risk of
heart failure (Table 1).
Autopsy recommendations
Patients presented at autopsy can be either operated at young
age (infants, severe disease), operated at older age, or not
operated at all. Typically, dilatation of the RV, tricuspid valve
annulus, and functional RV is observed. The valve annular
dilatation can reach 20 cm and is best visualized via an atrial
view, followed by opening of the RVoutflow, from the apex to
the pulmonary valve. From this incision, the cone reconstruc-
tion can be visualized optimally. The displaced leaflets, which
have dysplastic appearance, are usually attached to the ven-
tricular wall; the annular attachment of the anterior leaflet is
normally located, but the leaflet is often dysplastic and abun-
dant (sail like). Complications include infective endocarditis
Fig. 9 The different types of Fontan-type procedures, grouped in main
patterns (a–c). Direct atriopulmonary connection without interposition of
conduits (a). Intracardiac lateral tunnel draining the IVC into the pulmo-
nary circulation bypassing the right ventricle (b). Extracardiac conduit
draining the IVC blood into the pulmonary arteries (c). In (b) and (c), a
bidirectional Glenn anastomosis drains SVC blood to the right pulmonary
artery
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(operated and non-operated cases), systemic emboli, and pa-
thology related to ablation of arrhythmias (WPW syndrome)
or degeneration of a prosthetic valve. Not infrequently, left-
sided heart pathology can also be present: ventricular dilata-
tion, fibro elastosis, and left ventricular fibrofatty substitution.
Other valvar abnormalities, such as mitral valve prolapse and
a bicuspid aortic valve, have been reported (Table 1).
Anomalous pulmonary venous connections (return)
Description: One or more pulmonary veins connect to a site
other than the morphologically left atrium.
It can be total (diagnosed and repaired early in life) or partial,
when a solitary vein or all the venous connections from one lung
drain into the right-sided atrium or the superior vena cava. Most
frequently in adults, the right pulmonary veins drain into the
superior vena cava, often associated with the sinus venosus
ASD, or the right pulmonary veins drain into the right-sided
atrium. In the “scimitar syndrome,” one or two right-sided pul-
monary veins “pierce” the diaphragm and drain into the inferior
vena cava, and there is dextroposition of the heart because of
hypoplasia of the right lung; part of the lung can be sequestrated
in terms of its bronchial supply; anomalous pulmonary arterial
supply through systemic collateral arteries derived from the de-
scending aorta. In other cases of partial anomalous pulmonary
venous connection, the left pulmonary veins drain into the com-
mon venous truncus so that the blood enters the right atrium. The
presence of an ASD allows the survival of patients with total
anomalous pulmonary venous connection, with blood shunting
the systemic circulation.
The timing of surgery depends on the severity of obstruc-
tion to venous return and oxygen saturations. Partial anoma-
lous connections of the pulmonary veins may be of little func-
tional significance and can be an incidental finding or can
become symptomatic later in adulthood. Surgical repair “re-
routes” pulmonary venous return to the left atrium using an
autologous pericardial patch to create a tunnel in the right
atrium through the ASD (Table 1).
Autopsy recommendations
In surgically treated adult patients, the pathologist should exclude
pulmonary venous obstruction and residual lesions. In cases of
scimitar syndrome, the inferior vena cava should be examined, as
well as bronchial and pulmonary arterial supply to the right lung.
In unrepaired cases, left to right shunting typically results in right
heart dilatation. Histology of the lung vasculature is required to
exclude pulmonary vascular disease (Table 1).
Univentricular hearts after a Fontan-type procedure
Named after Francis Fontan, a brilliant French surgeon who
invented the procedure in 1968, the Fontan procedure and the
many modifications over the years are palliative surgical
a b c
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Fig. 10 Failing Fontan circulation with hepatic cirrhosis and pulmonary
hemorrhage (a–f): macroscopic view of the liver at autopsy, with
evidence of cirrhosis (a); histology showing fibrosis with
disorganization of the structure, dilatation of the veins, and regenerative
nodules using hematoxylin-eosin staining (b); Masson trichrome staining
highlighting the fibrosis in green (c); high-power view of c (d); lung
hemorrhage, hematoxylin and eosin staining (e); lung thrombosis (white
arrows), Masson trichrome staining (f)
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interventions designed for patients who cannot undergo
biventricular repair [59] (Table 2). There are many types of con-
genital anomalies that can be palliated by the Fontan and modi-
fied Fontan procedures all of which have in common the feature
of a univentricular physiology, whereby only one ventricle can
be used to support the systemic circulation (Fig. 9). For example,
in hypoplastic left heart syndrome, the LV is too small or inade-
quate to support the systemic circulation so the RV is, therefore,
recruited to support the systemic circulation instead. Other such
heart malformations are tricuspid atresia, pulmonary atresia with
intact ventricular septum, hypoplastic left heart syndrome,
double-inlet left or right ventricles, atrioventricular septal defect
with unbalanced ventricles, and single ventricle with undefined
morphology. The outcomes after these palliative procedures are
nowadays optimal when performed at a young age, with an
operative mortality of 5% and a midterm mortality at 10 years
of approximately 10% depending on the type of defect.
However, long-term complications are common and relate to
the lack of a subpulmonary ventricle, which produces chronic
systemic venous hypertension and a preload deprived systemic
ventricle. The modes of death vary: perioperative (68%), sudden
cardiac death (9%), thromboembolism (8%), heart failure (7%),
and sepsis (3%) [60]. Heart failure is becoming the most com-
mon cause of death in adult patients and those with a systemic
RV (Table 3). Liver complications are common late after Fontan
operation, including cirrhosis and hepatocellular carcinoma.
Protein-losing enteropathy and plastic bronchitis are also compli-
cations of the Fontan circulation.
The aim of a Fontan-type operation is to route the
systemic venous blood flow directly into the pulmonary
artery without the interposition of a ventricle. This can
be achieved in different ways. The oldest procedure im-
plies a direct atriopulmonary connection (right atrial ap-
pendage to pulmonary trunk which has been detached
from the pulmonary valve). More recently, the Fontan
procedure i s pe r fo rmed by means o f a to t a l
cavopulmonary connection, with an intracardiac tunnel
or an extracardiac conduit, draining the blood flow from
the inferior vena cava to the pulmonary artery, and with
a bidirectional cavopulmonary shunt (termed bidirection-
al Glenn shunt), draining the blood flow from the supe-
rior vena cava directly to the confluent pulmonary ar-
teries. The Fontan pathway may be fenestrated, allowing
communication with the left-sided atrial chamber, as an
escape (relief valve) mechanism in case of increasing
pressures following intervention (Fig. 9).
Autopsy recommendations
Late complications after Fontan procedures that should be
evaluated at autopsy include Fontan pathway obstruction (an-
atomical or thrombosis), right atrial dilatation, pulmonary ar-
tery stenosis or thrombosis, pulmonary vascular disease, atrio-
ventricular valve regurgitation, and pulmonary venous ob-
struction. A “failing Fontan” circulation is also characterized
by congestive heart failure with peripheral congestion, ascites,
pleural effusions, and multi-organ involvement, including he-
patic changes (hepatomegaly, cirrhosis, portal hypertension,
and hepatocellular carcinoma), protein loosing enteropathy,
and renal failure (Fig. 10a–c). Chylothorax and plastic
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Fig. 11 Congenital coronary
arteries anomalies in two adult
patients. Left coronary artery
originating from the wrong sinus,
running in front of the pulmonary
trunk, at low risk of SCD (a);
drawing of a coronary artery
anomaly with abnormal course
between the aorta and the
pulmonary arteries, at high risk of
SCD (b). High takeoff of the right
coronary artery above the
sinotubular junction, at low risk
of SCD (c)
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bronchitis can also occur in the medium term. Pulmonary
thrombosis and hemorrhage (Fig. 10d), arteriovenous
malformations, and venovenous collaterals are not
uncommon. A restrictive VSD may act as LVOT obstruction
in cases with transposed great arteries (Tables 1 and 2,
Tables S1–S3 supplement).
Table 3 Autopsy procedures
Appropriate photographic documentation of the hearts is recommended
Handling of the heart: Remove en bloc the heart and lungs with the thoracic
aorta for a proper complete evaluation. If a second opinion is sought the entire
block, and not only the heart, should be referred (after washout)
Fresh heart
Wash out to remove blood clots
Put crumpled paper towels or gauze soaked in formalin in ventricle cavities to
allow fixation without distortion
Take small ventricle pieces to be frozen
Put the heart in an appropriately sized container with sufficient 10% formalin to
cover
For proper valuation of surgical conduits and anastomosis, it is important to
investigate the heart lung specimen, with large arteries (pulmonary arteries
and aorta including aortic arch intact). When dissecting the heart, it is also
important to keep the roof of the atria with inflow of the pulmonary and
systemic veins intact
Gross examination before sectioning the heart Describe the heart: dimensions (hypertrophic, dilated, normal)
Consider a plain X-ray for localization of devices, catheters, calcifications, etc.
Weight the heart
Measure longitudinal distance (distance from the crux cordis to the apex on the
posterior aspect)
Transverse distance (from the obtuse to the acute margin along the posterior
atrioventricular sulcus)
Possible aneurysms
Describe amount and distribution of epicardial fat
Examine the atrial cuffs and atrial appendages for size, endocardial lesions and
thrombi
Examine atrioventricular valves (atrial view) and the semilunar valves (arterial
view) and note any abnormalities (mention bicuspid valve)
Non-operated congenital heart disease
Sectioning Before dissection, check whether the heart is biventricular or univentricular:
with univentricular physiology, it is essential to identify the rudimentary
ventricle
Dissect the heart following blood flow (a transverse cut at mid-ventricle is not
usually recommended)
Gross examination Use the sequential segmental approach whose main steps are the following:
Definition of atrial situs
Morphologic identification of atria, ventricles and great arteries
Recognition of atrioventricular and ventriculo-arterial connections
Sampling for histology Sample left and right ventricle.
Operated congenital heart disease
General recommendations Assess any devices, including valves and patches or biological grafts relating to
previous surgical or interventional procedures. (endocarditis, thrombosis)
Check for catheters within the cavities and epicardial leads
Sectioning Structure of the heart can be markedly altered; it is advisable to have a clear idea
of the primary disease and subsequent surgery before sectioning, if possible
with the surgeon or cardiologist present.
Coronary arteries Locate the coronary ostia and/or eventual aberrant course
Make transverse cuts at 3-mm intervals in the main epicardial branches to
identify atherosclerotic stenosis / occlusion (as usual)
Sampling for histology A complete section of the heart at mid-ventricular level is not recommended
In non-operated and operated hearts histological evaluation could be important
for dating the injuries or thrombosis or any complications and for assessing
the pathological substrates (fibrosis, ischemic injury, endocardial elastosis,
scars), which may contribute to cardiac failure and/ or arrhythmias. I would
recommend sampling of the heart for interstitial fibrosis and endocardial
elastosis of the right and left ventricle.
One sample from the right ventricle, one from the left ventricle.
Staining When warranted by hematoxylin-eosin, stains for collagen and elastic fibers
(Masson or Mallory trichrome, Movat pentachrome, Wiegert van Gieson,
etc.) and additional stains or immunohistochemistry on indication
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Coronary artery malformations
Description: Congenital malformations of the coronary arter-
ies are characterized by aberrant origin, course, or size of
epicardial arteries.
They occur either as isolated anomalies or in combination
with more complex congenital heart disease. Some of these are
relatively benign lesions, but others have an increased risk of
sudden death already early in life. For a detailed description of
the anomalies in this chapter, see the manuscript published by
the Development, Anatomy, and Pathology of the European
Society of Cardiology (ESC) working group [61]. An anoma-
lous origin of the left coronary artery from the pulmonary artery
(ALCAPA) is a rare high-risk condition that presents early in
life and causes early death in infancy unless repaired. However,
rare cases of SCD have been reported even in adulthood [62].
Origin of the left or right coronary artery from the opposite
(wrong) sinus is considered a low risk condition (Fig. 11a), ex-
cept when there is anomalous (interarterial) course between aorta
and pulmonary artery, in which case it is regarded as a “high-
risk” anomaly associated with SCD (Fig. 11b). The so-called
minor anomalies in coronary development have incidentally also
been reported to precipitate arrhythmic cardiac arrest due tomyo-
cardial ischemia, mostly during efforts or sports activity.
“High takeoff” of a coronary artery is considered as a low-risk
lesion (Fig. 11c), unless the artery exhibits also an intramural
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Fig. 12 Histology of vascular remodeling in pulmonary arterial hypertension (a–d). Concentric non-laminar intimal thickening Azan Mallory staining
(a), hematoxylin-eosin staining (b); medial muscular hypertrophy, Wiegert van Gieson staining (c); plexiform lesions, hematoxylin-eosin staining (d)
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(aortic) course, which may cause ischemia during exercise.
Coronary ostia originating up to 1.2 cm above the sinotubular
junction are considered variants without clinical significance [63].
Autopsy recommendations
The site of the coronary ostia and course should be document-
ed: exclude anomalous origin from the pulmonary artery or
from a wrong aortic sinus, assess the height and location of the
ostia in the ascending aorta, and whether there is an anoma-
lous intramural course or course between the aorta and pul-
monary artery. Take a vertical sample at a stenotic site for
histological examination. Myocardial histology should evalu-
ate acute (contraction bands) or late patchy fibrosis, indicating
ischemic injury in the myocardium at risk (Table 3).
Congenital anomalies of the conduction tissue
Congenital AV block and WPW syndrome may be associated
with SCD. Usually, diagnosis is accomplished at ECG follow-
ing syncope, epileptic seizures, or palpitations.
Congenital heart block in adolescents and adults is either
related to the underlying condition or the result of surgery or
intervention. It may also be precipitated by medication or
endocarditis. Indeed, permanent pacing is commonly required
in conditions such as those with congenitally corrected TGA
or atrioventricular septal defects.
Wolff-Parkinson-White syndrome consists of ventricular
preexcitation due to an anomalous AV connection of working
myocardium leading to re-entry supraventricular tachycardia.
Complicating factors such as atrial myocarditis and very short
refractory period of the accessory pathway may lead to ven-
tricular fibrillation and cardiac arrest [64].
Autopsy recommendations
Electrocardiograms should be examined from clinical records
prior to autopsy. In cases of suspected or established WPW, the
tricuspid valve should be examined to rule out Ebstein anomaly,
and myocarditis should be excluded. Histologic identification
and examination of the accessory pathways are usually not
required, because in nearly all cases diagnostic electrocardio-
gram is available. Systematic histological investigation of such
aberrant conduction pathways is very laborious and time-
consuming and is not routinely recommended.
Special considerations in cases of redo
surgical procedures
Prior to autopsy, the indications for the intervention and de-
tailed surgical reports should be examined, together with the
past medical history. Surgical re-interventions require longer
cardiopulmonary bypass and surgery time, impacting on peri-
operative hemostasis, myocardial, lung, and renal function.
Common reoperations are aortic or pulmonary valve replace-
ment, AVSD repair, RV-to-pulmonary artery conduit replace-
ments, Fontan (TCPC) conversion, aortic coarctation, and re-
pairs of Mustard pathways leaks or obstruction (Table 2).
Box 1
Template for Autopsy Report in Adult Congenital Heart Diseases
The pathology report should include a descriptive section and the final diagnosis.
Descriptive section should include:
• A sufficiently detailed clinical history with the native congenital heart disease, time and type of surgical and hybrid procedures.
• Systematic description of the macroscopic findings at autopsy.
• Systematic description of the microscopic findings, if required.
• Description of any additional tests, if performed.
To understand the gross autoptic findings, the pathologist at autopsy should be aware of the cardiac morphology in the different types of CHD, the
pathophysiology and the possible surgical or interventional techniques for palliation or repair. Microscopic and molecular findings should correlate to
the macroscopic autopsy findings before interpretation can be finalized. Before the release of the report the pathologist should always discuss findings
with the surgeon and the cardiologist.
Final diagnosis should include:
• Cause(s) of death.
• Description of the native congenital heart defect and status after surgical correction. (state remodeling of the heart, which includes also histological
appearance, chambers after surgery, and other complications)
• Pathologic findings in order organs (in order of priority)
• Description of the surgical and interventional procedures
• Epicrisis or clinicopathological correlations and comments.
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Perioperative mortality in these patients increases with age,
the complexity of the anomaly, the number of previous oper-
ations, and, not at least, the co-morbid pathology such as renal
failure, pulmonary hypertension, and obesity.
Autopsy recommendations
Previous interventions can result in dense mediastinal adhe-
sions, pericardial adhesions, lung scarring or atelectasis, and
chest deformities. Chronic cyanosis can affect hemostasis and
promotes perioperative bleeding, but paradoxically also
thrombosis, and may also cause renal failure. Causes or con-
tributors to death around redo procedures include ventricular
or organ dysfunction,, infections, embolic events (e.g., throm-
botic or air emboli), refractory congestive heart failure (e.g.,
persistent pleural effusion or ascites), migration of devices,
laceration or perforation of vital cardiac structures, and injury
to adjacent organs (e.g., the lung).
Pathology of themajor clinicalmanifestations
of ACHD
Heart failure
Heart failure (HF) is very often the clinical evolution in
ACHD patients, even those operated early in life in the
best clinical setting. HF can be part of the natural history
of a defect, and/or a sequela of previous palliation or
repair [65]. Heart transplantation is the ultimate option
for patients with advanced heart failure refractory to treat-
ment, with particular cases receiving mechanical circula-
tory support as destination therapy or as a bridge to trans-
plantation [66, 67]. Over 30% of ACHD patients are like-
ly to die of heart failure [68, 69]. All CHD can evolve to
HF, but at “high risk” are the patients unrepaired cyanotic
lesions and with univentricular hearts (failing Fontan cir-
culation). The most common mechanism for the develop-
ment of HF is ventricular dysfunction due to severe
pressure or volume overload, myocardial ischemia, and
prior surgery [70]. Ventricular dysfunction can also be
worsened by arrhythmias, which are the result of abnor-
malities in the conduction system or parietal wall scarring
due to surgery [71]. With the increase in survival of
ACHD patients, comorbidity also contributes to the devel-
opment of heart failure, which can be systemic hyperten-
sion, coronary atherosclerosis, myocarditis, diabetes
mellitus, smoking, or drug abuse. The occurrence of acute
heart failure must be also considered. This can be the
consequence of rapid progression of preexistent chronic
heart failure but can also be due to ischemia, acute coro-
nary syndromes, tachy- or bradyarrhythmias, valvular in-
sufficiency, cardiac tamponade, or pulmonary embolism
[7].
Autopsy recommendations
Systemic signs of heart failure, such as peripheral edema, pleural
effusions, lung congestion, ascites, liver congestion, gastritis, and
evidence of kidney failure, should be assessed. Any native CHD,
or the type of surgical or interventional procedures, residual le-
sions, and cardiac remodeling should be described, and the likely
mechanisms of heart failure should be identified. Conditions that
may precipitate chronic heart failure or determine acute heart
failure should also be identified (see above) (Table 3).
Pulmonary arterial hypertension
Patients with congenital heart disease (CHD) are frequently af-
fected by pulmonary arterial hypertension (PAH), especially
when large systemic-to-pulmonary shunts are left untreated or
are repaired late, before the onset of irreversible lung lesions
[72, 73]. When pulmonary vascular disease becomes severe
[74], the shunt reverses (from left to right to bidirectional) and
cyanosis appears in the landmarks of Eisenmenger syndrome
(ES) [75]. The exact prevalence of PAH in ACHD is unknown,
but a European registry reported an estimated prevalence be-
tween 5 to 10%, and about 25–50% of these patients had ES
[76]. International pulmonary hypertension guidelines classify
PAH related to CHD (PAH-CHD) into four categories: ES;
PAH associated with prevalent systemic-to-pulmonary shunts;
PAH with small/coincidental defects; and PAH persisting, recur-
ring, or developing after defect correction [77].
In general, the parameters associated with the onset and also
severity of PAH-CHD are the type and dimension of the congen-
ital defect, direction of the shunt, associated extracardiac anoma-
lies, and the type and timing of surgery (palliative or definitive).
Morbidity and mortality rates are significant in PAH-CHD
and are often the result of chronic hypoxia, cardiac dysfunction,
and refractory congestive HF or sepsis/infections. In many pa-
tients, death may be sudden, due to hemoptysis, pulmonary hy-
pertensive crisis, or arrhythmias of which the latter relate to long-
Box 2
Questions to be answered after autopsy:
What was the cause of death?
Was the preoperative diagnosis correct?
Could the death have been avoided?
Appropriate indication to repair or palliation? Timing of
surgical or interventional procedures?
Evaluation of surgical or interventional techniques.
Appropriate perioperative management.
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standing cardiac overload or myocardial scars [78]. Acute dete-
rioration of HF can also occur soon after inappropriate late clo-
sure of a septal defect or other communication, in ES patients, in
whom such defects act as “relief valves” for the RV. Pulmonary
causes of sudden onset death in PAH patients are thromboem-
bolic events or hemoptysis due to rupture of small or large pul-
monary vessels or bronchial arteries.
Autopsy recommendations
The autopsy should start with evaluation of the type of CHD and
associated anomalies and complications, such as endocarditis or
other infection. Extracardiac causes of death should also be con-
sidered, e.g., paradoxical emboli to the brain or brain abscess.
Dimensions of cardiac chambers are important to record: degree
of RA and RV dilatation and wall thickness of RV for hypertro-
phy, comparing this to the LV. Potential precipitating factors,
such as lung infection, thrombosis, myocardial ischemia and
postoperative reperfusion injury should be evaluated.
Macroscopic evidence of long-standing PAH includes presence
of dilated pulmonary arteries, with significant atherosclerotic
plaques (which can be even aneurysmatic and ulcerating in se-
vere cases) at the level of pulmonary trunk and pulmonary arter-
ies and stratified (in situ) thrombus.
Histology of each lobe is required to assess pulmonary
vascular disease. For correct handling of tissue, the lungs
should be fixed in a state of distension to avoid artifacts in
elastic laminae and exaggerated medial hypertrophy. The
main histological changes, in increasing order of severity,
are concentric intimal thickening, muscular hypertrophy and
dilatation of arterioles and small arteries, and the formation of
“plexiform lesions” in keeping with Heath-Edwards classifi-
cation. Fibrinoid necrosis is considered as an acute lesion,
secondary to intense vasoconstriction and endothelial damage
with insudation of fibrinogen into the arterial wall.
Hematoxylin-eosin and elastic van Gieson stains are essential;
immunohistochemical staining for smooth muscle cells (actin,
desmin) and endothelial cells (CD31, CD34) can sometimes
be of help to delineate the vascular pathology. The current
pathological classification of vasculopathies in PH was pro-
posed in 2003 at the Third World Symposium on Pulmonary
Hypertension [79] (Fig. 12) (Table 3).
Sudden cardiac death
Sudden cardiac death (SCD) is not uncommon in both
repaired and unrepaired/palliated ACHD patients (see also
AECVP guidelines on SCD) [80].
The mechanism of cardiac arrest is in most cases arrhyth-
mic, in the setting of severe electrical instability of the heart
with a complete heart block or life-threatening ventricular ar-
rhythmias arising in the “working” myocardium. Cases of
“mechanical SCD” are rare and include hemorrhages due to
aortic or pulmonary artery ruptures or dissections and
(thrombo) embolization or sudden death in patients with se-
vere obstructive lesions [81].
For practical purposes, there are three categories of patients
in whom SCD may occur:
1. Overt CHDs since birth or unrepaired CHD. This group
includes patients with unrepaired univentricular hearts or
with large septal defects who have developed significant
pulmonary vascular disease (ES).
2. Overt CHD since birth, repaired surgically or
percutaneously. Patients with repaired tetralogy of
Fallot carry a small but well-documented risk of sudden
death, often related to the scarring of the RVoutflow tract
as a consequence of infundibulotomy with transannular
patch or RV pulmonary artery conduit implantation.
Patients with systemic ventricular dysfunction (e.g., pa-
tients with a systemic RVafter atrial switch for TGA) and
those with Ebstein anomaly are at risk of sudden arrhyth-
mic death. Surgical or percutaneous repair of a VSD and
endocarditis of the aortic valve can affect the conduction
system, causing complete heart block.
3. Congenital heart disease diagnosed in adult life. There are
congenital cardiac anomalies that are not symptomatic at
birth, infancy or childhood. They remain silent and may be
diagnosed by chance, when an ECG or echocardiogram is
performed later for screening or other reasons. There are four
main categories to be excluded on autopsy: coronary artery
anomalies, conduction tissue defects, CCTGA, and the bi-
cuspid aortic valve (as described above).
Autopsy recommendations
See AECVP guidelines on SCD [80].
Conclusion
Significant knowledge and expertise are required to perform
an autopsy in an ACHD patient. This document provides an
overview of the most common types of ACHD and potential
autopsy findings including its interpretation in relation to the
clinical scenario at the time of death. As such, it may serve to
guide postmortem examinations performed by non-CHD pa-
thologists who need to perform autopsy in ACHD patients
(Table 3, Box 1–2). Close collaboration with tertiary CHD
centers is strongly recommended, discussing complex cases
and ensuring high-quality outcomes for clinical, medicolegal,
and educational purposes.
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